Clinical trial
Influence of Dexmedetomidine on the Evoked Potentials During Spine Surgery
NCT00494832 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00494832 |
|---|---|
| Title | Influence of Dexmedetomidine on the Evoked Potentials During Spine Surgery |
| Official title | Influence of Dexmedetomidine on the Evoked Potentials During Spine Surgery |
| Lead sponsor | University of Washington, Other |
| Collaborators | Hospira, now a wholly owned subsidiary of Pfizer Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Spine Surgery |
| Intervention type | Drug |
| Interventions | Dexmedetomidine, Normal Saline |
| Enrollment | 40 |
| Start date | Feb 1, 2008 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Jul 2, 2007 |
| Last update posted | Sep 14, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: